Source: BioSpectrum

BioReliance: Merck's BioReliance services help to ensure purity, safety and efficacy

Merck has launched its BioReliance® Product Characterization Portfolio of tests for quality assessment of biologic drugs. This new, comprehensive suite of tests, provides critical information that biologic manufacturers need as they design their production process.

Read full article »
Est. Annual Revenue
$100-500M
Est. Employees
500-1.0K
CEO Avatar

President & CEO

Charles C. Harwood, Jr

CEO Approval Rating

70/100

Read more